Medicare Enrolled
Dr. Gorgun Akpek, M.D., M.H.S.
Hematology & Oncology · San Luis Obispo, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Akpek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akpek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Akpek
Dr. Gorgun Akpek is a hematology & oncology specialist in San Luis Obispo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Akpek performed 1,630 Medicare services across 907 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akpek received a total of $25,592 from 91 pharmaceutical and/or device companies across 1120 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akpek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 42% volume in CA
$25,592 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,630
Medicare services
Top 42% in CA for hematology & oncology
907
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
624 | $73 | $196 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
450 | $98 | $285 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
154 | $141 | $310 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
95 | $84 | $238 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
75 | $71 | $165 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $135 | $429 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
56 | $47 | $101 |
| New patient office visit, complex (60-74 min) | 54 | $172 | $436 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $93 | $287 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
18 | $149 | $387 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $43 | $119 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,592
Total received (2018-2024)
Avg $3,656/year across 7 years
Top 18% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
91
Companies
1,120
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,741 (81.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,081 (12.0%)
Other
Charitable contributions, space rental, and other categories
$1,376 (5.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$394 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,960
2023
$3,878
2022
$4,007
2021
$5,260
2020
$2,785
2019
$1,505
2018
$196
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,683
Novartis Pharmaceuticals Corporation
$1,376
Janssen Biotech, Inc.
$524
Astellas Pharma US Inc
$439
Merck Sharp & Dohme LLC
$369
GlaxoSmithKline, LLC.
$364
ABBVIE INC.
$355
Daiichi Sankyo Inc.
$316
Exelixis Inc.
$245
Genentech USA, Inc.
$244
PFIZER INC.
$231
Celgene Corporation
$194
Takeda Pharmaceuticals U.S.A., Inc.
$175
Blueprint Medicines Corporation
$174
Lilly USA, LLC
$145
ADC Therapeutics America, Inc.
$98
SOBI, INC
$82
GENZYME CORPORATION
$75
Eisai Inc.
$70
E.R. Squibb & Sons, L.L.C.
$67
Gilead Sciences, Inc.
$64
EMD Serono, Inc.
$60
BeiGene USA, Inc.
$52
Apellis Pharmaceuticals, Inc.
$50
Incyte Corporation
$46
Alexion Pharmaceuticals, Inc.
$46
Alnylam Pharmaceuticals Inc.
$40
Blue Earth Diagnostics Limited
$33
Karyopharm Therapeutics Inc.
$32
Mirati Therapeutics, Inc.
$31
Janssen Pharmaceuticals, Inc
$26
ARRAY BIOPHARMA INC
$24
Deciphera Pharmaceuticals Inc.
$23
TAIHO ONCOLOGY, INC.
$23
Coherus Biosciences Inc.
$23
SERVIER PHARMACEUTICALS LLC
$22
SpringWorks Therapeutics, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Fresenius Kabi USA, LLC
$21
Aveo Pharmaceuticals, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
MorphoSys, US Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Janssen Scientific Affairs, LLC
$9
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,721
Janssen Biotech, Inc.
$2,318
Novartis Pharmaceuticals Corporation
$2,132
E.R. Squibb & Sons, L.L.C.
$1,571
Astellas Pharma US Inc
$1,418
Daiichi Sankyo Inc.
$886
Seagen Inc.
$864
Merck Sharp & Dohme LLC
$857
Amgen Inc.
$856
GlaxoSmithKline, LLC.
$810
Celgene Corporation
$663
PFIZER INC.
$620
Genentech USA, Inc.
$615
Exelixis Inc.
$582
Eisai Inc.
$552
Blueprint Medicines Corporation
$483
Incyte Corporation
$451
Pharmacyclics LLC, An AbbVie Company
$443
GENZYME CORPORATION
$424
Takeda Pharmaceuticals U.S.A., Inc.
$414
ABBVIE INC.
$403
Merck Sharp & Dohme Corporation
$381
Rigel Pharmaceuticals, Inc.
$235
Bayer HealthCare Pharmaceuticals Inc.
$229
Kite Pharma, Inc.
$221
Lilly USA, LLC
$211
Pharmacyclics LLC, an AbbVie Company
$210
Seattle Genetics, Inc.
$166
ADC Therapeutics America, Inc.
$157
EISAI INC.
$148
EMD Serono, Inc.
$144
AbbVie Inc.
$135
Janssen Scientific Affairs, LLC
$135
SOBI, INC
$131
Alexion Pharmaceuticals, Inc.
$121
JAZZ PHARMACEUTICALS INC.
$120
Karyopharm Therapeutics Inc.
$118
Boehringer Ingelheim Pharmaceuticals, Inc.
$118
AMAG Pharmaceuticals, Inc.
$112
Bayer Healthcare Pharmaceuticals Inc.
$111
MorphoSys, US Inc.
$111
Puma Biotechnology, Inc.
$108
Gilead Sciences, Inc.
$102
TOLMAR Pharmaceuticals, Inc.
$101
SANOFI-AVENTIS U.S. LLC
$100
Clovis Oncology, Inc.
$94
Secura Bio, Inc.
$94
Sobi, Inc
$88
BeiGene USA, Inc.
$87
Regeneron Healthcare Solutions, Inc.
$84
ARRAY BIOPHARMA INC
$82
AVEO Pharmaceuticals, Inc.
$81
Myovant Sciences Inc.
$76
Ipsen Biopharmaceuticals, Inc
$71
Mirati Therapeutics, Inc.
$70
Apellis Pharmaceuticals, Inc.
$69
PUMA BIOTECHNOLOGY, INC.
$66
Coherus Biosciences Inc.
$63
Dova Pharmaceuticals
$60
TAIHO ONCOLOGY, INC.
$48
Kyowa Kirin, Inc.
$43
Deciphera Pharmaceuticals Inc.
$43
Myriad Genetic Laboratories, Inc.
$41
Alnylam Pharmaceuticals Inc.
$40
Janssen Pharmaceuticals, Inc
$39
Blue Earth Diagnostics Limited
$33
Acrotech Biopharma LLC
$30
TerSera Therapeutics LLC
$25
SERVIER PHARMACEUTICALS LLC
$22
SpringWorks Therapeutics, Inc.
$22
Fresenius Kabi USA, LLC
$21
Aveo Pharmaceuticals, Inc.
$19
Sirtex Medical Inc
$19
CTI BioPharma Corp.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$17
ImmunoGen, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$16
Heron Therapeutics, Inc.
$15
G1 Therapeutics, Inc.
$15
Stemline Therapeutics Inc.
$15
Teva Pharmaceuticals USA, Inc.
$15
Agios Pharmaceuticals, Inc.
$15
Foundation Medicine, Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$15
Organon LLC
$14
Mylan Institutional Inc.
$13
Sun Pharmaceutical Industries Inc.
$13
Epizyme, Inc.,
$13
TESARO, Inc.
$12
NOVARTIS PHARMACEUTICALS CORPORATION
$12
SECURA BIO, INC.
$9
Top 3 companies account for 28.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Andexxa · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYNFEZIA PEN · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COPIKTRA · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · FARYDAK · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · Itovebi · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leqembi · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · PreciseTumor · QINLOCK · REBLOZYL · RYBREVANT · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · Stimufend · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (81%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
9
Per 100K population
3.2
County median income
$93,398
Nearest hospital
FRENCH HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Akpek is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Akpek experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Akpek performed 624 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akpek receive payments from pharmaceutical companies?
Yes. Dr. Akpek received a total of $25,592 from 91 companies across 1,120 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akpek's costs compare to other hematology & oncology specialists in San Luis Obispo?
Dr. Akpek's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akpek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Luis Obispo
Browse hematology & oncology specialists in San Luis Obispo ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology